BCT, breast-conserving therapy; IBC, inflammatory breast cancer; NAC, neoadjuvant chemotherapy; LABC, locally advanced breast cancer; HER2, human epidermal growth factor receptor-2; RCT, randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results. Here, ERBB2 is linked to breast cancer.